MedTrace Logo

Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

NCT00344370 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2010-02-02

Study results available
· View outcomes & findings →

Summary

This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.

Conditions

Interventions

DRUG

Pitavastatin

Pitavastatin 4 mg QD

DRUG

Atorvastatin

Atorvastatin 40 mg

Sponsors & Collaborators

  • Kowa Research Europe

    lead INDUSTRY

Principal Investigators

  • Dragos Budinski, MD · Kowa Research Europe (KRE)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • Denmark
  • Germany
  • India
  • Netherlands
  • Poland
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00344370 on ClinicalTrials.gov